The Truth About Premature Ejaculation

Ampio Pharmaceutical has announced that the results of it’s latest clinical trials for the drug Zertane currently in it’s final phase of trials, has exceeded expectations.

We don’t know when the drug will be launched but we know that they are targeting the European market first. It is also not clear what the mechanism of action of Zertane is but according to Ampio’s website:

The active ingredient in Zertane™ has multiple mechanisms of actions that can delay ejaculation. This drug also has an excellent safety record established during 30 years of human use. These unique pharmaceutical qualities, exceptional human safety record, and a distinctive non-standard dosage not available in generic form, differentiate Zertane™ from other treatments for premature ejaculation.

Our guess is that it is not an SSRI drug like Priligy but we’ll keep you posted.